Cargando…
The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MA...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142088/ https://www.ncbi.nlm.nih.gov/pubmed/21659498 http://dx.doi.org/10.2337/db10-1220 |
_version_ | 1782208792382930944 |
---|---|
author | Ndip, Agbor Williams, Alfred Jude, Edward B. Serracino-Inglott, Ferdinand Richardson, Steve Smyth, J.V. Boulton, Andrew J.M. Alexander, M. Yvonne |
author_facet | Ndip, Agbor Williams, Alfred Jude, Edward B. Serracino-Inglott, Ferdinand Richardson, Steve Smyth, J.V. Boulton, Andrew J.M. Alexander, M. Yvonne |
author_sort | Ndip, Agbor |
collection | PubMed |
description | OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MAC) seen in people with CN are unclear. This study aimed to investigate the role of RANKL/OPG in MAC in patients with CN. RESEARCH DESIGN AND METHODS: Enzyme-linked immunosorbent assay and Bio-plex multiarray technology were used to quantify a range of cytokines, including RANKL and OPG in sera from 10 patients with diabetes, 12 patients with CN, and 5 healthy volunteers. Human tibial artery segments were immunohistochemically stained with Alizarin red and human RANKL antibody. Human vascular smooth muscle cells (VSMCs) were also explanted from arterial segments for in vitro studies. RESULTS: We demonstrate colocalization and upregulation of RANKL expression in areas displaying MAC. Systemic levels of RANKL, OPG, and inflammatory cytokines (interleukin-8, granulocyte colony–stimulating factor) were elevated in those with CN compared with diabetic patients and healthy control subjects. Human VSMCs cultured in CN serum showed accelerated osteoblastic differentiation (alkaline phosphatase activity) and mineralization (alizarin red staining) compared with cells treated with diabetic or control serum (P < 0.05). Coincubation with OPG, the decoy receptor for RANKL, attenuated osteogenic differentiation of VSMCs and was independent of a high calcium-phosphate milieu. The accelerated mineralization induced by RANKL and CN serum correlated with nuclear translocation of nuclear factor-κB, a process abrogated by OPG. CONCLUSIONS: Our data provide direct evidence that RANKL/RANK/OPG signaling is modulated in patients with CN and plays a role in vascular calcification. This study highlights this pathway as a potential target for intervention. |
format | Online Article Text |
id | pubmed-3142088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-31420882012-08-01 The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy Ndip, Agbor Williams, Alfred Jude, Edward B. Serracino-Inglott, Ferdinand Richardson, Steve Smyth, J.V. Boulton, Andrew J.M. Alexander, M. Yvonne Diabetes Complications OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MAC) seen in people with CN are unclear. This study aimed to investigate the role of RANKL/OPG in MAC in patients with CN. RESEARCH DESIGN AND METHODS: Enzyme-linked immunosorbent assay and Bio-plex multiarray technology were used to quantify a range of cytokines, including RANKL and OPG in sera from 10 patients with diabetes, 12 patients with CN, and 5 healthy volunteers. Human tibial artery segments were immunohistochemically stained with Alizarin red and human RANKL antibody. Human vascular smooth muscle cells (VSMCs) were also explanted from arterial segments for in vitro studies. RESULTS: We demonstrate colocalization and upregulation of RANKL expression in areas displaying MAC. Systemic levels of RANKL, OPG, and inflammatory cytokines (interleukin-8, granulocyte colony–stimulating factor) were elevated in those with CN compared with diabetic patients and healthy control subjects. Human VSMCs cultured in CN serum showed accelerated osteoblastic differentiation (alkaline phosphatase activity) and mineralization (alizarin red staining) compared with cells treated with diabetic or control serum (P < 0.05). Coincubation with OPG, the decoy receptor for RANKL, attenuated osteogenic differentiation of VSMCs and was independent of a high calcium-phosphate milieu. The accelerated mineralization induced by RANKL and CN serum correlated with nuclear translocation of nuclear factor-κB, a process abrogated by OPG. CONCLUSIONS: Our data provide direct evidence that RANKL/RANK/OPG signaling is modulated in patients with CN and plays a role in vascular calcification. This study highlights this pathway as a potential target for intervention. American Diabetes Association 2011-08 2011-07-18 /pmc/articles/PMC3142088/ /pubmed/21659498 http://dx.doi.org/10.2337/db10-1220 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Complications Ndip, Agbor Williams, Alfred Jude, Edward B. Serracino-Inglott, Ferdinand Richardson, Steve Smyth, J.V. Boulton, Andrew J.M. Alexander, M. Yvonne The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title | The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title_full | The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title_fullStr | The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title_full_unstemmed | The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title_short | The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy |
title_sort | rankl/rank/opg signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy |
topic | Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142088/ https://www.ncbi.nlm.nih.gov/pubmed/21659498 http://dx.doi.org/10.2337/db10-1220 |
work_keys_str_mv | AT ndipagbor theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT williamsalfred theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT judeedwardb theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT serracinoinglottferdinand theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT richardsonsteve theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT smythjv theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT boultonandrewjm theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT alexandermyvonne theranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT ndipagbor ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT williamsalfred ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT judeedwardb ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT serracinoinglottferdinand ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT richardsonsteve ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT smythjv ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT boultonandrewjm ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy AT alexandermyvonne ranklrankopgsignalingpathwaymediatesmedialarterialcalcificationindiabeticcharcotneuroarthropathy |